PL-06 platelet CLEC-2 and podoplanin in cancer metastasis

Thrombosis Research

Volumn 129, Issue SUPPL. 1, 2012, Pages

  Lowe, Kate L ^a   Navarro Nunez, Leyre ^a   Watson, Stephen P ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Cancer; CLEC 2; Platelets; Podoplanin; Syk; Thrombosis

Indexed keywords

ACTIN; C TYPE LECTIN RECEPTOR 2; GUANOSINE TRIPHOSPHATASE; LECTIN RECEPTOR; PODOPLANIN; UNCLASSIFIED DRUG; CLEC2B PROTEIN, HUMAN; LECTIN; MEMBRANE PROTEIN; PDPN PROTEIN, HUMAN;

ACTIN FILAMENT; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CONFERENCE PAPER; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; METASTASIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIALYLATION; SIGNAL TRANSDUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; ANIMAL; ARTICLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; HUMANS; LECTINS, C-TYPE; MEMBRANE GLYCOPROTEINS; NEOPLASM METASTASIS;

EID: 84862140232     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/S0049-3848(12)70013-0     Document Type: Conference Paper

References (125)

1. CL Chaffer, RA Weinberg A perspective on cancer cell metastasis Science 331 6024 2011 1559 1564
2. Trousseau A. Phlegmasia alba dolens. In: Balliere JB (editors), Clinique Medicale de l'Hotel-Dieu de Paris, 2nd ed. Paris, France: 1865, 3:654-712.
3. FR Rickles, A Falanga Molecular basis for the relationship between thrombosis and cancer Throm Res 102 6 2001 V215 V224
4. BL Tranum, A Haut Thrombocytosis: platelet kinetics in neoplasia J Lab Clin Med 84 5 1974 615 619
5. S Karpatkin, E Pearlstein Role of platelets in tumor cell metastases Ann Intern Med 95 5 1981 636 641 (Pubitemid 12231807)
6. E Camerer, AA Qazi, DN Duong, I Cornelissen, R Advincula, SR Coughlin Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis Blood 104 2 2004 397 401 (Pubitemid 38900020)
7. GJ Gasic, TB Gasic, CC Stewart Antimetastatic effects associated with platelet reduction Proc Natl Acad Sci U S A 61 1 1968 46 52
8. MA Brockmann, A Giese, K Mueller, FJ Kaba, F Lohr, C Weiss et al. Preoperative thrombocytosis predicts poor survival in patients with glioblastoma Neuro-oncology 9 3 2007 335 342 (Pubitemid 47169666)
9. M Ikeda, H Furukawa, H Imamura, J Shimizu, H Ishida, S Masutani et al. Poor prognosis associated with thrombocytosis in patients with gastric cancer Ann Surg Oncol 9 3 2002 287 291 (Pubitemid 34298634)
10. U Kuyumcuoglu, AI Guzel, Y Celik, M Erdemoglu The association of preoperative thrombocytosis with prognostic factors in malign ovarian tumor Eur J Gynaecol Oncol 31 5 2010 514 516
11. S Taucher, A Salat, M Gnant, W Kwasny, B Mlineritsch, RC Menzel et al. Impact of pretreatment thrombocytosis on survival in primary breast cancer Thromb Haemost 89 6 2003 1098 1106 (Pubitemid 36798163)
12. KM Brown, C Domin, GV Aranha, S Yong, M Shoup Increased preoperative platelet count is associated with decreased survival after resection for adenocarcinoma of the pancreas Am J Surg 189 3 2005 278 282 (Pubitemid 40431945)
13. A Ayhan, G Bozdag, C Taskiran, M Gultekin, K Yuce, T Kucukali The value of preoperative platelet count in the prediction of cervical involvement and poor prognostic variables in patients with endometrial carcinoma Gynecol Oncol 103 3 2006 902 905 (Pubitemid 44830067)
14. V Costantini, LR Zacharski, TE Moritz, RL Edwards The platelet count in carcinoma of the lung and colon Thromb Haemost 64 4 1990 501 505
15. K Sasaki, K Kawai, NH Tsuno, E Sunami, J Kitayama Impact of preoperative thrombocytosis on the survival of patients with primary colorectal cancer World J Surg 36 1 2012 192 200
16. F Erdemir, M Kilciler, S Bedir, Y Ozgok, H Coban, K Erten Clinical significance of platelet count in patients with renal cell carcinoma Urol Int 79 2 2007 111 116 (Pubitemid 47402734)
17. L Erpenbeck, MP Schon Deadly allies: the fatal interplay between platelets and metastasizing cancer cells Blood 115 17 2010 3427 3436
18. P Jurasz, D Alonso-Escolano, MW Radomski Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation Br J Pharmacol 143 7 2004 819 826 (Pubitemid 39664840)
19. M Labelle, S Begum, RO Hynes Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis Cancer Cell 20 5 2011 576 590
20. Y Kato, N Fujita, A Kunita, S Sato, M Kaneko, M Osawa et al. Molecular identification of Aggrus/T1alpha as a platelet aggregation-inducing factor expressed in colorectal tumors J Biol Chem 278 51 2003 51599 51605 (Pubitemid 38020404)
21. K Suzuki-Inoue, O Inoue, G Ding, S Nishimura, K Hokamura, K Eto et al. Essential in vivo roles of the C-type lectin receptor CLEC-2: embryonic/neonatal lethality of CLEC-2-deficient mice by blood/lymphatic misconnections and impaired thrombus formation of CLEC-2-deficient platelets J Biol Chem 285 32 2010 24494 24507
22. A Wicki, F Lehembre, N Wick, B Hantusch, D Kerjaschki, G Christofori Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton Cancer Cell 9 4 2006 261 272
23. CE Hughes, AY Pollitt, J Mori, JA Eble, MG Tomlinson, JH Hartwig et al. CLEC-2 activates Syk through dimerization Blood 115 14 2010 2947 2955
24. AA Watson, CM Christou, JR James, AE Fenton-May, GE Moncayo, AR Mistry et al. The platelet receptor CLEC-2 is active as a dimer Biochemistry 48 46 2009 10988 10996
25. K Suzuki-Inoue, GL Fuller, A Garcia, JA Eble, S Pohlmann, O Inoue et al. A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2 Blood 107 2 2006 542 549 (Pubitemid 43076377)
26. T Krause, GA Turner Are selectins involved in metastasis? Clin Exp Metastasis 17 3 1999 183 192 (Pubitemid 29360896)
27. A Janowska-Wieczorek, M Wysoczynski, J Kijowski, L Marquez-Curtis, B Machalinski, J Ratajczak et al. Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer Int J Cancer 113 5 2005 752 760 (Pubitemid 40101256)
28. H Boukerche, O Berthier-Vergnes, F Penin, E Tabone, G Lizard, M Bailly et al. Human melanoma cell lines differ in their capacity to release ADP and aggregate platelets Br J Haematol 87 4 1994 763 772 (Pubitemid 24264649)
29. D Alonso-Escolano, AY Strongin, AW Chung, EI Deryugina, MW Radomski Membrane type-1 matrix metalloproteinase stimulates tumour cell-induced platelet aggregation: role of receptor glycoproteins Br J Pharmacol 141 2 2004 241 252 (Pubitemid 38250894)
30. NM Bambace, CE Holmes The platelet contribution to cancer progression J Thromb Haemost 9 2 2011 237 249
31. ML Nierodzik, A Klepfish, S Karpatkin Role of platelets, thrombin, integrin IIb-IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo Thromb Haemost 74 1 1995 282 290
32. KV Honn, P Cavanaugh, C Evens, JD Taylor, BF Sloane Tumor cell-platelet aggregation: induced by cathepsin B-like proteinase and inhibited by prostacyclin Science 217 4559 1982 540 542 (Pubitemid 12099336)
33. B Olas, WP Mielicki, B Wachowicz, T Krajewski Cancer procoagulant stimulates platelet adhesion Thromb Res 94 3 1999 199 203 (Pubitemid 29217201)
34. EI Deryugina, JP Quigley Matrix metalloproteinases and tumor metastasis Cancer Metastasis Rev 25 1 2006 9 34 (Pubitemid 43723979)
35. H Laubli, L Borsig Selectins promote tumor metastasis Semin Cancer Biol 20 3 2010 169 177
36. R Kannagi, M Izawa, T Koike, K Miyazaki, N Kimura Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis Cancer Sci 95 5 2004 377 384 (Pubitemid 38832679)
37. RS Bresalier, SB Ho, HL Schoeppner, YS Kim, MH Sleisenger, P Brodt et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis Gastroenterology 110 5 1996 1354 1367 (Pubitemid 26134066)
38. YJ Kim, L Borsig, NM Varki, A Varki P-selectin deficiency attenuates tumor growth and metastasis Proc Natl Acad Sci U S A 95 16 1998 9325 9330 (Pubitemid 28506230)
39. J Zhang, J Nakayama, C Ohyama, M Suzuki, A Suzuki, M Fukuda et al. Sialyl Lewis X-dependent lung colonization of B16 melanoma cells through a selectin-like endothelial receptor distinct from E- or P-selectin Cancer Res 62 15 2002 4194 4198 (Pubitemid 34827270)
40. JR Brown, MM Fuster, T Whisenant, JD Esko Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys J Biol Chem 278 26 2003 23352 23359 (Pubitemid 36830150)
41. L Borsig, R Wong, RO Hynes, NM Varki, A Varki Synergistic effects of L- and P-selectin in facilitating tumor metastasis can involve non-mucin ligands and implicate leukocytes as enhancers of metastasis Proc Natl Acad Sci U S A 99 4 2002 2193 2198 (Pubitemid 34169037)
42. OJ McCarty, SA Mousa, PF Bray, K Konstantopoulos Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions Blood 96 5 2000 1789 1797 (Pubitemid 30661063)
43. H Kitagawa, N Yamamoto, K Yamamoto, K Tanoue, G Kosaki, H Yamazaki Involvement of platelet membrane glycoprotein Ib and glycoprotein IIb/IIIa complex in thrombin-dependent and -independent platelet aggregations induced by tumor cells Cancer Res 49 3 1989 537 541 (Pubitemid 19050310)
44. S Jain, M Zuka, J Liu, S Russell, J Dent, JA Guerrero et al. Platelet glycoprotein Ib alpha supports experimental lung metastasis Proc Natl Acad Sci U S A 104 21 2007 9024 9028 (Pubitemid 47175430)
45. S Jain, J Harris, J Ware Platelets: linking hemostasis and cancer Arterioscler Thromb Vasc Biol 30 12 2010 2362 2367
46. S Jain, S Russell, J Ware Platelet glycoprotein VI facilitates experimental lung metastasis in syngenic mouse models J Thromb Haemost 7 10 2009 1713 1717
47. LJ Gay, B Felding-Habermann Contribution of platelets to tumour metastasis Nat Rev Cancer 11 2 2011 123 134
48. SJ Bakewell, P Nestor, S Prasad, MH Tomasson, N Dowland, M Mehrotra et al. Platelet and osteoclast beta3 integrins are critical for bone metastasis Proc Natl Acad Sci U S A 100 24 2003 14205 14210 (Pubitemid 37499215)
49. M Trikha, Z Zhou, J Timar, E Raso, M Kennel, E Emmell et al. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis Cancer Res 62 10 2002 2824 2833 (Pubitemid 34525767)
50. A Amirkhosravi, SA Mousa, M Amaya, S Blaydes, H Desai, T Meyer et al. Inhibition of tumor cell-induced platelet aggregation and lung metastasis by the oral GpIIb/IIIa antagonist XV454 Thromb Haemost 90 3 2003 549 554 (Pubitemid 37138780)
51. B Felding-Habermann, R Habermann, E Saldivar, ZM Ruggeri Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow J Biol Chem 271 10 1996 5892 5900
52. B Felding-Habermann, TE O'Toole, JW Smith, E Fransvea, ZM Ruggeri, MH Ginsberg et al. Integrin activation controls metastasis in human breast cancer Proc Natl Acad Sci U S A 98 4 2001 1853 1858 (Pubitemid 32165587)
53. S Even-Ram, B Uziely, P Cohen, S Grisaru-Granovsky, M Maoz, Y Ginzburg et al. Thrombin receptor overexpression in malignant and physiological invasion processes Nat Med 4 8 1998 909 914 (Pubitemid 28364029)
54. M Zigler, T Kamiya, EC Brantley, GJ Villares, M Bar-Eli PAR-1 and thrombin: the ties that bind the microenvironment to melanoma metastasis Cancer Res 71 21 2011 6561 6566
55. ML Nierodzik, S Karpatkin Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype Cancer Cell 10 5 2006 355 362 (Pubitemid 44693468)
56. W Ruf, J Disse, TC Carneiro-Lobo, N Yokota, F Schaffner Tissue factor and cell signalling in cancer progression and thrombosis J Thromb Haemost 9 Suppl 1 2011 306 315
57. JS Palumbo, KE Talmage, JV Massari, CM La Jeunesse, MJ Flick, KW Kombrinck et al. Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells Blood 105 1 2005 178 185 (Pubitemid 40053080)
58. JS Palumbo, KE Talmage, JV Massari, CM La Jeunesse, MJ Flick, KW Kombrinck et al. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms Blood 110 1 2007 133 141 (Pubitemid 47026828)
59. C Philippe, B Philippe, B Fouqueray, J Perez, M Lebret, L Baud Protection from tumor necrosis factor-mediated cytolysis by platelets Am J Pathol 143 6 1993 1713 1723 (Pubitemid 24058274)
60. B Nieswandt, M Hafner, B Echtenacher, DN Mannel Lysis of tumor cells by natural killer cells in mice is impeded by platelets Cancer Res 59 6 1999 1295 1300 (Pubitemid 29136261)
61. HG Kopp, T Placke, HR Salih Platelet-derived transforming growth factor-beta down-regulates NKG2D thereby inhibiting natural killer cell antitumor reactivity Cancer Res 69 19 2009 7775 7783
62. S Huang, M Van Arsdall, S Tedjarati, M McCarty, W Wu, R Langley et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice J Natl Cancer Inst 94 15 2002 1134 1142 (Pubitemid 34919050)
63. C Belloc, H Lu, C Soria, R Fridman, Y Legrand, S Menashi The effect of platelets on invasiveness and protease production of human mammary tumor cells Int J Cancer 60 3 1995 413 417
64. E Sierko, MZ Wojtukiewicz Platelets and angiogenesis in malignancy Seminars in thrombosis and hemostasis 30 1 2004 95 108 (Pubitemid 38457304)
65. SS Smyth, RP McEver, AS Weyrich, CN Morrell, MR Hoffman, GM Arepally et al. Platelet functions beyond hemostasis J Thromb Haemost 7 11 2009 1759 1766
66. T Eichholtz, K Jalink, I Fahrenfort, WH Moolenaar The bioactive phospholipid lysophosphatidic acid is released from activated platelets Biochem J 291 Pt 3 1993 677 680 (Pubitemid 23148436)
67. A Boucharaba, CM Serre, S Gres, JS Saulnier-Blache, JC Bordet, J Guglielmi et al. Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer J Clin Invest 114 12 2004 1714 1725 (Pubitemid 40385527)
68. GP Gupta, J Massague Platelets and metastasis revisited: a novel fatty link J Clin Invest 114 12 2004 1691 1693 (Pubitemid 40385522)
69. T Minami, A Sugiyama, SQ Wu, R Abid, T Kodama, WC Aird Thrombin and phenotypic modulation of the endothelium Arterioscler Thromb Vasc Biol 24 1 2004 41 53 (Pubitemid 38082410)
70. O Dashevsky, D Varon, A Brill Platelet-derived microparticles promote invasiveness of prostate cancer cells via upregulation of MMP-2 production Int J Cancer 124 8 2009 1773 1777
71. A Janowska-Wieczorek, LA Marquez-Curtis, M Wysoczynski, MZ Ratajczak Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells Transfusion 46 7 2006 1199 1209 (Pubitemid 44139495)
72. HM Verheul, K Hoekman, S Luykx-de Bakker, CA Eekman, CC Folman, HJ Broxterman et al. Platelet: transporter of vascular endothelial growth factor Clin Cancer Res 3 12 Pt 1 1997 2187 2190 (Pubitemid 28133134)
73. ME Daly, A Makris, M Reed, CE Lewis Hemostatic regulators of tumor angiogenesis: a source of antiangiogenic agents for cancer treatment? J Natl Cancer Inst 95 22 2003 1660 1673 (Pubitemid 37509075)
74. JE Italiano Jr., JL Richardson, S Patel-Hett, E Battinelli, A Zaslavsky, S Short et al. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released Blood 111 3 2008 1227 1233 (Pubitemid 351213404)
75. M Chatterjee, Z Huang, W Zhang, L Jiang, K Hultenby, L Zhu et al. Distinct platelet packaging, release, and surface expression of proangiogenic and antiangiogenic factors on different platelet stimuli Blood 117 14 2011 3907 3911
76. VS Ossovskaya, NW Bunnett Protease-activated receptors: contribution to physiology and disease Physiol Rev 84 2 2004 579 621 (Pubitemid 38365493)
77. Y Liu, P Jiang, K Capkova, D Xue, L Ye, SC Sinha et al. Tissue factor-activated coagulation cascade in the tumor microenvironment is critical for tumor progression and an effective target for therapy Cancer Res 71 20 2011 6492 6502
78. E Martin-Villar, FG Scholl, C Gamallo, MM Yurrita, M Munoz-Guerra, J Cruces et al. Characterization of human PA2.26 antigen (T1alpha-2, podoplanin), a small membrane mucin induced in oral squamous cell carcinomas Int J Cancer 113 6 2005 899 910 (Pubitemid 40096869)
79. Y Shen, CS Chen, H Ichikawa, GS Goldberg SRC induces podoplanin expression to promote cell migration J Biol Chem 285 13 2010 9649 9656
80. A Gandarillas, FG Scholl, N Benito, C Gamallo, M Quintanilla Induction of PA2.26, a cell-surface antigen expressed by active fibroblasts, in mouse epidermal keratinocytes during carcinogenesis Mol Carcinog 20 1 1997 10 18 (Pubitemid 27461534)
81. J Shibahara, T Kashima, Y Kikuchi, A Kunita, M Fukayama Podoplanin is expressed in subsets of tumors of the central nervous system Virchows Arch 448 4 2006 493 499
82. K Mishima, Y Kato, MK Kaneko, R Nishikawa, T Hirose, M Matsutani Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression Acta Neuropathol 111 5 2006 483 488
83. Y Kato, I Sasagawa, M Kaneko, M Osawa, N Fujita, T Tsuruo Aggrus: a diagnostic marker that distinguishes seminoma from embryonal carcinoma in testicular germ cell tumors Oncogene 23 52 2004 8552 8556 (Pubitemid 39540806)
84. V Schacht, SS Dadras, LA Johnson, DG Jackson, YK Hong, M Detmar Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors Am J Pathol 166 3 2005 913 921 (Pubitemid 40315647)
85. Y Kato, M Kaneko, M Sata, N Fujita, T Tsuruo, M Osawa Enhanced expression of Aggrus (T1alpha/podoplanin), a platelet-aggregation-inducing factor in lung squamous cell carcinoma Tumour Biol 26 4 2005 195 200 (Pubitemid 41379745)
86. N Kimura, I Kimura Podoplanin as a marker for mesothelioma Pathol Int 55 2 2005 83 86 (Pubitemid 40343728)
87. JP Rodrigo, D Garcia-Carracedo, MV Gonzalez, G Mancebo, MF Fresno, J Garcia-Pedrero Podoplanin expression in the development and progression of laryngeal squamous cell carcinomas Mol Cancer 9 2010 48
88. A Kunita, TG Kashima, Y Morishita, M Fukayama, Y Kato, T Tsuruo et al. The platelet aggregation-inducing factor aggrus/podoplanin promotes pulmonary metastasis Am J Pathol 170 4 2007 1337 1347 (Pubitemid 47339340)
89. K Suzuki-Inoue, Y Kato, O Inoue, MK Kaneko, K Mishima, Y Yatomi et al. Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells J Biol Chem 282 36 2007 25993 26001 (Pubitemid 47443800)
90. A Kunita, TG Kashima, A Ohazama, AE Grigoriadis, M Fukayama Podoplanin is regulated by AP-1 and promotes platelet aggregation and cell migration in osteosarcoma Am J Pathol 179 2 2011 1041 1049
91. DM Underhill, HS Goodridge The many faces of ITAMs Trends Immunol 28 2 2007 66 73 (Pubitemid 46176733)
92. MG Tomlinson, J Lin, A Weiss Lymphocytes with a complex: adapter proteins in antigen receptor signaling Immunol Today 21 11 2000 584 591
93. GL Fuller, JA Williams, MG Tomlinson, JA Eble, SL Hanna, S Pohlmann et al. The C-type lectin receptors CLEC-2 and Dectin-1, but not DC-SIGN, signal via a novel YXXL-dependent signaling cascade J Biol Chem 282 17 2007 12397 12409 (Pubitemid 47100620)
94. LN Cueni, L Chen, H Zhang, D Marino, R Huggenberger, A Alitalo et al. Podoplanin-Fc reduces lymphatic vessel formation in vitro and in vivo and causes disseminated intravascular coagulation when transgenically expressed in the skin Blood 116 20 2010 4376 4384
95. Y Kato, MK Kaneko, A Kunita, H Ito, A Kameyama, S Ogasawara et al. Molecular analysis of the pathophysiological binding of the platelet aggregation-inducing factor podoplanin to the C-type lectin-like receptor CLEC-2 Cancer Sci 99 1 2008 54 61 (Pubitemid 350239031)
96. V Schacht, MI Ramirez, YK Hong, S Hirakawa, D Feng, N Harvey et al. T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema EMBO J 22 14 2003 3546 3556 (Pubitemid 36898332)
97. P Uhrin, J Zaujec, JM Breuss, D Olcaydu, P Chrenek, H Stockinger et al. Novel function for blood platelets and podoplanin in developmental separation of blood and lymphatic circulation Blood 115 19 2010 3997 4005
98. CC Bertozzi, AA Schmaier, P Mericko, PR Hess, Z Zou, M Chen et al. Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling Blood 116 4 2010 661 670
99. BA Finney, E Schweighoffer, L Navarro-Nunez, C Benezech, F Barone, CE Hughes et al. CLEC-2 and Syk in the megakaryocytic/platelet lineage are essential for development Blood 119 7 2012 1747 1756
100. H Ichise, T Ichise, O Ohtani, N Yoshida Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice Development 136 2 2009 191 195
101. JL Clements, JR Lee, B Gross, B Yang, JD Olson, A Sandra et al. Fetal hemorrhage and platelet dysfunction in SLP-76-deficient mice J Clin Invest 103 1 1999 19 25 (Pubitemid 29031159)
102. M Turner, PJ Mee, PS Costello, O Williams, AA Price, LP Duddy et al. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk Nature 378 6554 1995 298 302
103. AM Cheng, B Rowley, W Pao, A Hayday, JB Bolen, T Pawson Syk tyrosine kinase required for mouse viability and B-cell development Nature 378 6554 1995 303 306
104. L Carramolino, J Fuentes, C Garcia-Andres, V Azcoitia, D Riethmacher, M Torres Platelets play an essential role in separating the blood and lymphatic vasculatures during embryonic angiogenesis Circ Res 106 7 2010 1197 1201
105. A Navarro, RE Perez, M Rezaiekhaligh, SM Mabry, II Ekekezie T1alpha/podoplanin is essential for capillary morphogenesis in lymphatic endothelial cells Am J Physiol Lung Cell Mol Physiol 295 4 2008 L543 L551
106. E Martin-Villar, D Megias, S Castel, MM Yurrita, S Vilaro, M Quintanilla Podoplanin binds ERM proteins to activate RhoA and promote epithelial- mesenchymal transition J Cell Sci 119 Pt 21 2006 4541 4553 (Pubitemid 44830653)
107. JP Thiery Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 6 2002 442 454
108. U Cavallaro, G Christofori Cell adhesion and signalling by cadherins and Ig-CAMs in cancer Nat Rev Cancer 4 2 2004 118 132 (Pubitemid 38198740)
109. FG Scholl, C Gamallo, S Vilaro, M Quintanilla Identification of PA2.26 antigen as a novel cell-surface mucin-type glycoprotein that induces plasma membrane extensions and increased motility in keratinocytes J Cell Sci 112 Pt 24 1999 4601 4613 (Pubitemid 30034809)
110. A Bretscher, K Edwards, RG Fehon ERM proteins and merlin: integrators at the cell cortex Nat Rev Mol Cell Biol 3 8 2002 586 599
111. LN Cueni, I Hegyi, JW Shin, A Albinger-Hegyi, S Gruber, R Kunstfeld et al. Tumor lymphangiogenesis and metastasis to lymph nodes induced by cancer cell expression of podoplanin Am J Pathol 177 2 2010 1004 1016
112. T Matsui, M Maeda, Y Doi, S Yonemura, M Amano, K Kaibuchi et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association J Cell Biol 140 3 1998 647 657 (Pubitemid 28134067)
113. A Wicki, G Christofori The potential role of podoplanin in tumour invasion Br J Cancer 96 1 2007 1 5 (Pubitemid 46094630)
114. JM Lee, S Dedhar, R Kalluri, EW Thompson The epithelial-mesenchymal transition: new insights in signaling, development, and disease J Cell Biol 172 7 2006 973 981
115. U Cavallaro, B Schaffhauser, G Christofori Cadherins and the tumour progression: is it all in a switch? Cancer Lett 176 2 2002 123 128 (Pubitemid 34136010)
116. AK Perl, P Wilgenbus, U Dahl, H Semb, G Christofori A causal role for E-cadherin in the transition from adenoma to carcinoma Nature 392 6672 1998 190 193 (Pubitemid 28162793)
117. FG Scholl, C Gamallo, M Quintanilla Ectopic expression of PA2.26 antigen in epidermal keratinocytes leads to destabilization of adherens junctions and malignant progression Lab Invest 80 11 2000 1749 1759
118. AJ Ridley Rho GTPases and cell migration J Cell Sci 114 Pt 15 2001 2713 2722 (Pubitemid 32785451)
119. E Sahai, CJ Marshall RHO-GTPases and cancer Nat Rev Cancer 2 2 2002 133 142
120. E Sahai, CJ Marshall ROCK and Dia have opposing effects on adherens junctions downstream of Rho Nat Cell Biol 4 6 2002 408 415 (Pubitemid 34746158)
121. M Kaneko, Y Kato, A Kunita, N Fujita, T Tsuruo, M Osawa Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells J Biol Chem 279 37 2004 38838 38843 (Pubitemid 39296043)
122. M Komatsu, CA Carraway, NL Fregien, KL Carraway Reversible disruption of cell-matrix and cell-cell interactions by overexpression of sialomucin complex J Biol Chem 272 52 1997 33245 33254 (Pubitemid 28023672)
123. KL Carraway, N Fregien, KL Carraway 3rd, CA Carraway Tumor sialomucin complexes as tumor antigens and modulators of cellular interactions and proliferation J Cell Sci 103 Pt 2 1992 299 307
124. Y Kato, MK Kaneko, A Kuno, N Uchiyama, K Amano, Y Chiba et al. Inhibition of tumor cell-induced platelet aggregation using a novel anti-podoplanin antibody reacting with its platelet-aggregation-stimulating domain Biochem Biophys Res Commun 349 4 2006 1301 1307 (Pubitemid 44416399)
125. Y Nakazawa, S Takagi, S Sato, T Oh-hara, S Koike, M Takami et al. Prevention of hematogenous metastasis by neutralizing mice and its chimeric anti-Aggrus/podoplanin antibodies Cancer Sci 102 11 2011 2051 2057